Loading
BioFrontier 2027
International Conference on Biomedical Research, Biotechnology & Precision Health 2027
A day where laboratory science, clinical practice and computation meet, from genomics and drug discovery to the diagnostics and digital tools reshaping precision health.
International Conference on Biomedical Research, Biotechnology & Precision Health 2027
BioFrontier 2027 is the second day of the FrontierMeet programme and is devoted to biomedical research, biotechnology and precision health. It is built for the conversation between bench scientists, clinicians, computational biologists and the companies translating discovery into therapy and diagnosis.
The programme treats translation as a scientific question rather than an afterthought. Research presentations are paired with discussion of evidence, reproducibility, regulation and the practical path from finding to patient. Contributions are welcome from research institutes, hospitals, universities and industry.
Five tracks
Tracks organise the programme and the review process. Work that spans tracks is welcome and should indicate its primary track.
- Genomics, proteomics and bioinformaticsSequencing, multi-omics integration, computational methods and data standards.
- Biotechnology and drug discoveryTarget identification, screening, biologics, cell and gene therapies and process development.
- Precision medicine and diagnosticsStratification, biomarkers, companion diagnostics and clinical validation.
- Digital health and AI in healthcareClinical decision support, medical imaging, remote monitoring and evaluation in practice.
- Systems biology and translational researchModels of biological systems and the evidence needed to move findings toward the clinic.
The room we are composing
- Biomedical and life-science researchers
- Clinicians and clinical researchers
- Bioinformaticians and computational biologists
- Biotechnology and pharmaceutical scientists
- Digital health and medical AI teams
- Public-health, regulatory and policy specialists
Present where translation is taken seriously
Your audience will include the clinicians and industry scientists who decide whether a finding travels.
Bring computation and biology into one room
Sessions are designed so that wet-lab, clinical and computational work can be discussed together.
Connect with AI and hardware neighbours
Intelligence 2027 precedes this day and Silicon 2027 follows it. Delegates may attend across days.
Be recognised for evidence
Recognitions reward rigorous, reproducible work with a clear path to impact.
One day, five movements
The shape of the day. Exact times, session titles and speakers will be published with the programme and are not yet set.
Registration and opening
Registration, welcome and a framing of the day's translational questions.
Research presentations
Peer-reviewed presentations organised by track, with time held for questions after each.
Key discussions and panels
Moderated discussion on evidence, reproducibility and the path from finding to clinical use.
Networking and poster engagement
Structured time with posters and their authors, and unstructured time to meet.
Recognition and closing
Recognition of selected contributions and a short closing address.
Honest status
We publish what is confirmed and label what is not. This ledger is the authoritative record for BioFrontier 2027.
- Details forthcomingThe call for papers will describe tracks, formats, the review process and the timeline. It has not yet been published.
- Confirmations in progressInvited speakers are being approached. No speaker is confirmed, and none will be listed until confirmed in writing.
- Appointments in progressAppointments to the Scientific Programme Committee, Peer Review Panel and Session Chairs are in progress.
- Announcement coming soonThe conference will take place in Las Vegas, USA. The specific venue will be announced once confirmed.
- Opening date forthcomingRegistration will open on a date to be announced. Fees and any student arrangements will be published with it.
Recognition at BioFrontier 2027
Recognitions at BioFrontier 2027 will follow the FrontierMeet award categories. Eligibility, evaluation criteria and the confirmed structure will be published before nominations open.
Questions about BioFrontier 2027, submissions, reviewing or institutional participation:
biofrontier2027@frontiermeet.com